The effect of Adacolumn ® on ulcerative colitis with COVID-19.

The effect of Adacolumn® on ulcerative colitis with COVID-19. Rev Esp Enferm Dig. 2020 Jun 04;112:511 Authors: Pérez Roldán F, Bernardos Martín ME, González Carro P Abstract Crespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process. PMID: 32496122 [PubMed - as supplied by publisher]
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Tags: Rev Esp Enferm Dig Source Type: research